Skip to main content
. Author manuscript; available in PMC: 2016 Nov 1.
Published in final edited form as: J Trauma Acute Care Surg. 2015 Nov;79(5):726–731. doi: 10.1097/TA.0000000000000839

Table 1.

Demographic and Baseline Characteristics of 443 Trauma Patients

Age at Trauma, median [IQR]; years 48 [28, 65]
Male sex; n (%) 313 (70.7%)
Blunt mechanism; n (%) 423 (95.5%)
ISS, median [IQR] 13.0 [6.0, 22.0]
Hospital LOS, median [IQR]; days 4.0 [2.0, 10.0]
Death; n (%) 14 (3.2%)
INR (admission), median [IQR] 1.0 [1.0, 1.1]
PTT (admission), median [IQR]; seconds 26.0 [24.0, 29.0]
Hemoglobin (admission), median [IQR]; g/dL 13.7 [12.0, 14.8]
RBC median [IQR]; units(First 24 Hours of Arrival)* 4 [2, 7]
Plasma median [IQR]; units(First 24 Hours of Arrival)* 5 [2, 6]
Platelet median [IQR]; units(First 24 Hours of Arrival)* 2 [1, 2]
Cryoprecipitate median [IQR]; units(First 24 Hours of Arrival)* 2 [1, 2]
Tranexamic Acid Administration in Pre-Hospital or ED (%) 10 (2.3%)
Bebulin (PCC) Infusion in Pre-Hospital or ED (%) 4 (1%)
*

Median [IQR] amongst the patients who received each type of blood product within the first 24 hours of arrival (77 patients received RBC, 53 patients received plasma, 51 patients received platelets and 14 patients received cryoprecipitate)